John Pottage
Direktor/Vorstandsmitglied bei SPERO THERAPEUTICS, INC.
Vermögen: 21 450 $ am 30.04.2024
Aktive Positionen von John Pottage
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SPERO THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 14.08.2018 | - |
Independent Dir/Board Member | 14.08.2018 | - | |
Global Virus Network
Global Virus Network Miscellaneous Commercial ServicesCommercial Services Global Virus Network conducts research on essential and critical defense against viral diseases. The non-profit company is based in Baltimore, MD. The company was founded by William Walmsley Hall and Robert C. Gallo. | Direktor/Vorstandsmitglied | 03.05.2022 | - |
Karriereverlauf von John Pottage
Ehemalige bekannte Positionen von John Pottage
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PARDES BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 14.09.2022 | 30.08.2023 |
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2009 | 01.10.2019 |
Corporate Officer/Principal | 01.11.2009 | 01.10.2019 | |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | 01.06.2007 | 01.11.2009 |
ACHILLION PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2002 | 14.05.2007 |
Vertex Pharmaceuticals (Canada), Inc.
Vertex Pharmaceuticals (Canada), Inc. Miscellaneous Commercial ServicesCommercial Services Vertex Pharmaceuticals (Canada), Inc. operates as a biotechnology company that invests in scientific innovation to create medicines for people with serious and life-threatening diseases. It discovered medicines to treat the cause of cystic fibrosis a genetic disease. The company is headquartered in Toronto, Canada. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.1998 | 01.05.2002 |
Rush Medical College | Corporate Officer/Principal | - | - |
Ausbildung von John Pottage
St. Louis University | Undergraduate Degree |
Colgate University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Spanien | 2 |
Kanada | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 3 |
Director/Board Member | 3 |
Sektoral
Health Technology | 6 |
Consumer Services | 4 |
Commercial Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SPERO THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 6 |
---|---|
Achillion Pharmaceuticals, Inc.
Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA. | Health Technology |
Vertex Pharmaceuticals (Canada), Inc.
Vertex Pharmaceuticals (Canada), Inc. Miscellaneous Commercial ServicesCommercial Services Vertex Pharmaceuticals (Canada), Inc. operates as a biotechnology company that invests in scientific innovation to create medicines for people with serious and life-threatening diseases. It discovered medicines to treat the cause of cystic fibrosis a genetic disease. The company is headquartered in Toronto, Canada. | Commercial Services |
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Health Technology |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
Global Virus Network
Global Virus Network Miscellaneous Commercial ServicesCommercial Services Global Virus Network conducts research on essential and critical defense against viral diseases. The non-profit company is based in Baltimore, MD. The company was founded by William Walmsley Hall and Robert C. Gallo. | Commercial Services |
Pardes Biosciences, Inc.
Pardes Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Pardes Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing and commercializing novel therapeutics to treat and prevent viral diseases. It also focuses on developing novel drugs to solve pandemic-sized problems like the coronavirus disease. The company was founded by Uri A. Lopatin and Lee D. Arnold on February 27, 2020 and is headquartered in Carlsbad, CA. | Health Technology |
- Börse
- Insiders
- John Pottage
- Erfahrung